ARCHIVES

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

This article is from The Cancer Letter archive.

Vol. 20 No. 42 | November 4, 1994

Download PDF Visit The Full Archive

Related Articles

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87

October 10, 1986

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

NCI Budget Picture: New Grants Down, No New Center Awards, Many Projects Left Unfunded

December 10, 1976

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998